In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model
RSC Advances · 2024 · 14 (31) · 22113-22122
DOI: 10.1039/d4ra03419h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Yifei Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine Changsha 410208 China 003872@hnucm.edu.cn. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Hunan University of Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose: the aim of this study was to improve the stability and bioavailability of paeoniflorin (PF) by using nanoparticle encapsulation technology.
Autor:innen und Institutionen
- School of Pharmacy, Hunan University of Chinese Medicine Changsha 410208 China 003872@hnucm.edu.cn.
- School of Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208 China.
Förderung
- Hunan University of Chinese Medicine
- National Natural Science Foundation of China
Zitieren
APA
Xiao, Y., Wei, Q., Du, L., Guo, Z., & Li, Y. (2024). In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model. RSC Advances, 14(31), 22113-22122. https://doi.org/10.1039/d4ra03419h
Vancouver
Xiao Y, Wei Q, Du L, Guo Z, Li Y. In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model. RSC Advances. 2024;14(31):22113-22122. doi:10.1039/d4ra03419h
BibTeX
@article{Xiao2024,
author = {Xiao, Yifei and Wei, Qidong and Du, Lixin and Guo, Zhihua and Li, Ya},
title = {In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {31},
pages = {22113--22122},
doi = {10.1039/d4ra03419h}
}
EUVIMED